Literature DB >> 33091575

The role of viruses in adenocarcinoma development.

Mohsen Nakhaie1, Javad Charostad2, Gholam Abbas Kaydani3, Ebrahim Faghihloo4.   

Abstract

Cancer is a leading public health issue that accounts for million deaths around the world every year. Human cancers contain over 100 types, which are categorized into different groups. Adenocarcinoma is one of those categories of cancer that begins from the glans and involves various tissues such as lung, esophagus, pancreas, prostate and colorectal. A range of risk factors has been identified for the development and progression of adenocarcinomas. One of these risk factors are viruses that serves special mechanisms to affect important host cell factors and tumorigenic pathways, contributing in development and promotion of adenocarcinomas. Here, we summarized the main viruses and their mechanisms implicated in the course of various adenocarcinomas development.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Neoplasm; Viruses

Year:  2020        PMID: 33091575     DOI: 10.1016/j.meegid.2020.104603

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  3 in total

Review 1.  Message in hand: the application of CRISPRi, RNAi, and LncRNA in adenocarcinoma.

Authors:  Ting Wang; Yunhong Yao; Xinrong Hu; Yi Zhao
Journal:  Med Oncol       Date:  2022-07-14       Impact factor: 3.738

2.  Establishment and Validation of a Ferroptosis-Related Gene Signature to Predict Overall Survival in Lung Adenocarcinoma.

Authors:  Su Wang; Zhen Xie; Zenghong Wu
Journal:  Front Genet       Date:  2022-01-14       Impact factor: 4.599

3.  Molecular and Serological Prevalence of HCMV in Iranian Patients with Breast Cancer.

Authors:  Mohsen Nakhaie; Javad Charostad; Azarakhsh Azaran; Seyyed Ali Mohammad Arabzadeh; Azim Motamedfar; Sara Iranparast; Fatemeh Ahmadpour; Abdolhasan Talaeizadeh; Manoochehr Makvandi
Journal:  Asian Pac J Cancer Prev       Date:  2021-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.